Across TCGA pan-cancer cohorts, OR14A16 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated OR14A16 data layer compared with 14 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher OR14A16 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR14A16 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

HNSC and UCEC are the cancer types where OR14A16 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	II,III,IV	0.078	0.695	<.001	9	view →
UCEC	DFS	Median	All	1.000	0.636	.043	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: OR14A16 tumor-vs-normal RNA expression · all OR14A16 data types